Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM

NACompletedINTERVENTIONAL

Enrollment

338

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

October 1, 2023

Study Completion Date

January 2, 2024

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

GLP-1 receptor agonist

GLP-1 RA was injected subcutaneously at standard dose and frequency for consecutive 6 months in patients with T2DM

Trial Locations (1)

Department of Endocrinology, Xuzhou

All Listed Sponsors

lead

The Affiliated Hospital of Xuzhou Medical University

OTHER

NCT05037045 - Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM | Biotech Hunter | Biotech Hunter